Insider · CIK 0001431872

van den Broek Richard

Reports to the SEC for 7 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001431872

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,423 sh	—	—	8,423
2025-08-15	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-04-08	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+11.6K sh	—	—	11,649
2023-05-25	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-05-25	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+28.5K sh	—	—	28,487
2023-05-19	PhaseBio Pharmaceuticals IncA Award	Director	AAward	+3,750 sh	—	—	0
2023-05-19	PhaseBio Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	0
2022-05-19	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-05-19	PhaseBio Pharmaceuticals IncRestricted Stock UnitsA Award	Director	AAward	+3,750 sh	—	—	3,750
2022-05-19	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-19	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+79.2K sh	—	—	79,206
2021-06-03	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-05-20	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-05-20	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,069 sh	—	—	9,069
2020-08-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2020-06-03	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-05-09	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+2,750 sh	—	—	2,750
2019-02-27	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-02-27	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+23K sh	—	—	23,000
2016-06-08	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	233,500
2016-06-08	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-06-23	STANDARD DIVERSIFIED INC.A Award	Director	AAward	+2,500 sh	—	—	28,230
2015-06-23	STANDARD DIVERSIFIED INC.OptionA Award	Director	AAward	+10K sh	—	—	10,000
2015-06-10	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	8,500
2015-06-10	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.3K sh	—	—	10,300
2015-05-26	PHARMACYCLICS INCU Disposition from Tender	Director	UDisposition from Tender	−29.6K sh	$261.25	−$7.74M	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,258 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,619 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,555 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,139 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,140 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,240 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,976 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,784 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,409 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,052 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−515 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−510 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−546 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−343 sh	—	—	0
2015-05-26	PHARMACYCLICS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,750 sh	—	—	0

Recent filings

Accepted (ET)
Jun 154
van den Broek Richard0001610717-26-000219
SEC(opens sec.gov)
Jun 154
van den Broek Richard0001437749-26-020719
SEC(opens sec.gov)
Aug 194
van den Broek Richard0001437749-25-027401
SEC(opens sec.gov)
Apr 94
van den Broek Richard0001610717-25-000098
SEC(opens sec.gov)
Jun 244
van den Broek Richard0001437749-24-021129
SEC(opens sec.gov)
Jun 64
van den Broek Richard0001437749-23-016801
SEC(opens sec.gov)
May 194
van den Broek Richard0001169245-23-000033
SEC(opens sec.gov)
May 234
van den Broek Richard0001104659-22-064005
SEC(opens sec.gov)
May 204
van den Broek Richard0001169245-22-000060
SEC(opens sec.gov)
Jun 44
van den Broek Richard0001169245-21-000065
SEC(opens sec.gov)
May 214
van den Broek Richard0001209191-21-035012
SEC(opens sec.gov)
Aug 104
van den Broek Richard0001209191-20-045891
SEC(opens sec.gov)
Jun 54
van den Broek Richard0001169245-20-000065
SEC(opens sec.gov)

Companies

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545